Jeffrey D. Kent
2Patents
1h-index
9Co-inventors
37Inventor score
Filing activity: Apr 10, 2007 → Jan 30, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9399061B2 | Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis | Emerging Cross-Sectional Technologies | 8 | Active |
| US12121566B2 | Methods for treating gout | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.